1-4 of 4
Penny Wallace
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Estimation of Resting Energy Expenditure Considering Effects of Race and Diabetes Status

Kelley Martin, RD, MPH, Penny Wallace, RN, MSN, Philip F. Rust, PHD, W. Timothy Garvey, MD
Journal: Diabetes Care
Diabetes Care 2004;27(6):1405–1411
https://doi.org/10.2337/diacare.27.6.1405
Published: 01 June 2004
View articletitled, Estimation of Resting Energy Expenditure Considering Effects of Race and Diabetes Status
Open the PDF for Estimation of Resting Energy Expenditure Considering Effects of Race and Diabetes Status in another window
Journal Articles

Critical Evaluation of Adult Treatment Panel III Criteria in Identifying Insulin Resistance With Dyslipidemia

Youlian Liao, PHD, Soonho Kwon, MD, Sara Shaughnessy, MS, RD, Penny Wallace, MS, RN, Amy Hutto, RN, Alicia J. Jenkins, MD, Richard L. Klein, PHD, W. Timothy Garvey, MD
Journal: Diabetes Care
Diabetes Care 2004;27(4):978–983
https://doi.org/10.2337/diacare.27.4.978
Published: 01 April 2004
View articletitled, Critical Evaluation of Adult Treatment Panel III Criteria in Identifying Insulin Resistance With Dyslipidemia
Open the PDF for Critical Evaluation of Adult Treatment Panel III Criteria in Identifying Insulin Resistance With Dyslipidemia in another window
Journal Articles

Intensive Conventional Insulin Therapy for Type II Diabetes: Metabolic effects during a 6-mo outpatient trial

Robert R Henry, MD, Barry Gumbiner, MD, Timothy Ditzler, BA, Penny Wallace, RN, Rachel Lyon, RD, Harry S Glauber, MD
Journal: Diabetes Care
Diabetes Care 1993;16(1):21–31
https://doi.org/10.2337/diacare.16.1.21
Published: 01 January 1993
View articletitled, Intensive Conventional Insulin Therapy for Type II Diabetes: Metabolic effects during a 6-mo outpatient trial
Open the PDF for Intensive Conventional Insulin Therapy for Type II Diabetes: Metabolic effects during a 6-mo outpatient trial in another window
Journal Articles

Metabolic Effects of New Oral Hypoglycemic Agent CS-045 in NIDDM Subjects

Stephan L Suter, MD, John J Nolan, MD, Penny Wallace, RN, Barry Gumbiner, MD, Jerrold M Olefsky, MD
Journal: Diabetes Care
Diabetes Care 1992;15(2):193–203
https://doi.org/10.2337/diacare.15.2.193
Published: 01 February 1992
View articletitled, Metabolic Effects of New Oral Hypoglycemic Agent CS-045 in NIDDM Subjects
Open the PDF for Metabolic Effects of New Oral Hypoglycemic Agent CS-045 in NIDDM Subjects in another window